These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 28638885)

  • 21. Underutilization of preventive strategies in patients receiving NSAIDs.
    Sturkenboom MC; Burke TA; Dieleman JP; Tangelder MJ; Lee F; Goldstein JL
    Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guilty as charged: bugs and drugs in gastric ulcer.
    Sontag SJ
    Am J Gastroenterol; 1997 Aug; 92(8):1255-61. PubMed ID: 9260785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prostaglandins and the prevention of non-steroidal antirheumatic drug-induced gastric lesions].
    Miederer SE
    Fortschr Med; 1989 Mar; 107(10):63-4, 67-8. PubMed ID: 2497057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of NSAID-induced ulcer disease.
    Clearfield HR
    Am Fam Physician; 1992 Jan; 45(1):255-8. PubMed ID: 1728095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs.
    Taha AS; Hudson N; Hawkey CJ; Swannell AJ; Trye PN; Cottrell J; Mann SG; Simon TJ; Sturrock RD; Russell RI
    N Engl J Med; 1996 May; 334(22):1435-9. PubMed ID: 8618582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Geranylgeranylacetone protects membranes against nonsteroidal anti-inflammatory drugs.
    Ushijima H; Tanaka K; Takeda M; Katsu T; Mima S; Mizushima T
    Mol Pharmacol; 2005 Oct; 68(4):1156-61. PubMed ID: 16046660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 30-day mortality after peptic ulcer perforation among users of newer selective COX-2 inhibitors and traditional NSAIDs: a population-based study.
    Thomsen RW; Riis A; Munk EM; Nørgaard M; Christensen S; Sørensen HT
    Am J Gastroenterol; 2006 Dec; 101(12):2704-10. PubMed ID: 17026569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Misoprostol in the prevention of NSAID-induced gastric ulcer: a multicenter, double-blind, placebo-controlled trial.
    Roth SH
    J Rheumatol Suppl; 1990 Feb; 20():20-4. PubMed ID: 2109073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the antiulcerogenic activity of Maytenus robusta (Celastraceae) in different experimental ulcer models.
    de Andrade SF; Lemos M; Comunello E; Noldin VF; Filho VC; Niero R
    J Ethnopharmacol; 2007 Sep; 113(2):252-7. PubMed ID: 17629427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The role of mucoprotective drugs in a treatment and prevention for NSAID-induced gastric ulcer].
    Okuyama M; Tominaga K; Tanigawa T; Shiba M; Watanabe T; Fujiwara Y; Oshitani N; Higuchi K; Arakawa T
    Nihon Rinsho; 2007 Oct; 65(10):1850-5. PubMed ID: 17926535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL; Huang B; Amer F; Christopoulos NG
    Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of acid suppressants in prophylaxis of NSAID damage.
    Chan FK; Sung JJ
    Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):433-45. PubMed ID: 11403537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genotypes of Helicobacter pylori obtained from gastric ulcer patients taking or not taking NSAIDs.
    Li L; Kelly LK; Ayub K; Graham DY; Go MF
    Am J Gastroenterol; 1999 Jun; 94(6):1502-7. PubMed ID: 10364014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Misoprostol: a prostaglandin for peptic ulcer.
    DiPalma JR
    Am Fam Physician; 1989 Aug; 40(2):217-9. PubMed ID: 2502901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Propolis and Its Gastroprotective Effects on NSAID-Induced Gastric Ulcer Disease: A Systematic Review.
    Ruiz-Hurtado PA; Garduño-Siciliano L; Domínguez-Verano P; Balderas-Cordero D; Gorgua-Jiménez G; Canales-Álvarez O; Canales-Martínez MM; Rodríguez-Monroy MA
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonsteroidal antiinflammatory drug-associated gastric ulcers do not require Helicobacter pylori for their development.
    Laine L; Marin-Sorensen M; Weinstein WM
    Am J Gastroenterol; 1992 Oct; 87(10):1398-402. PubMed ID: 1415094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Challenges in managing NSAID-associated gastrointestinal tract injury.
    Goldstein JL
    Digestion; 2004; 69 Suppl 1():25-33. PubMed ID: 15001832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequency of NSAID induced peptic ulcer disease.
    Hamid S; Yakoob J; Jafri W; Islam S; Abid S; Islam M
    J Pak Med Assoc; 2006 May; 56(5):218-22. PubMed ID: 16767948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NSAID is inversely associated with asymptomatic gastric ulcer: local health examination data from the Korean National Health Insurance Corporation.
    Kim HM; Cho JH; Choi JY; Chun SW; Kim YJ; Cho HG; Song SY; Han KJ
    Scand J Gastroenterol; 2013 Dec; 48(12):1371-6. PubMed ID: 24067057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Guideline 'NSAID use and the prevention of gastric damage'].
    Moens HJ; van Croonenborg JJ; Al MJ; van den Bemt PM; Lourens J; Numans ME;
    Ned Tijdschr Geneeskd; 2004 Mar; 148(13):604-8. PubMed ID: 15083624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.